Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB26FKRKE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,234
Award facts
- Contract value 100% obligated
- $3,234.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,234.25 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. The award, issued on November 7, 2025, with an ultimate completion date of December 2, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. DMS Pharmaceutical Group Inc. is performing the work at its facility in Park Ridge, Illinois, and will deliver the pharmaceutical product to support Department of Defense medical supply requirements.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical sourcing for military healthcare facilities worldwide. The underlying IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical regional prime vendor contractor for the Department of Defense. Through this vehicle, the company supplies an extensive portfolio of branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support recurring medical supply needs across the military healthcare system.
Quick answers
Who was awarded contract SPE2DB26FKRKE?
SPE2DB26FKRKE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DB26FKRKE worth?
The government has obligated $3,234 on SPE2DB26FKRKE.
Is contract SPE2DB26FKRKE an order under another contract?
Yes. SPE2DB26FKRKE is a delivery order under SPE2DB24D9314, an indefinite delivery contract.
Was contract SPE2DB26FKRKE competed?
The extent of competition for SPE2DB26FKRKE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award